Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)
Xtant Medical Holdings (XTNT) reported Restructuring Costs of $388000.0 for Q4 2018, down 79.21% year-over-year from $1.9 million in Q4 2017, and down 36.81% quarter-over-quarter from $614000.0 in Q3 2018.
Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018) Analysis & Trends
Xtant Medical Holdings (XTNT) has 2 years of Restructuring Costs data on file, last reported at $388000.0 in Q4 2018.
- Restructuring Costs for Q4 2018 came in at $388000.0, down 79.21% year-over-year; the trailing twelve-month figure through Dec 2018 was $3.0 million (down 36.72% YoY), and the FY2018 annual result was $3.0 million, down 36.54% from the prior year.
- Restructuring Costs retreated to $388000.0 in Q4 2018 per XTNT's latest filing, from $614000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $1.9 million in Q4 2017 and troughed at $388000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 62.75 Mn | 45.42 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 388,000.00 |
| Sep 30, 2018 | 614,000.00 |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 733,000.00 |
| Dec 31, 2017 | 1.87 Mn |
| Sep 30, 2017 | 1.19 Mn |
| Jun 30, 2017 | 1.63 Mn |